Vanguard Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-7,316,604
| Closed | -$29.3M | – | 4125 |
|
|
2019
Q4 | $29.3M | Buy |
7,316,604
+1,495,333
| +26% | +$5.98M | ﹤0.01% | 2345 |
|
|
2019
Q3 | $28.5M | Buy |
5,821,271
+113,166
| +2% | +$555K | ﹤0.01% | 2308 |
|
|
2019
Q2 | $34.8M | Buy |
5,708,105
+185,431
| +3% | +$1.13M | ﹤0.01% | 2281 |
|
|
2019
Q1 | $32.1M | Sell |
5,522,674
-131,645
| -2% | -$765K | ﹤0.01% | 2291 |
|
|
2018
Q4 | $76.1M | Buy |
5,654,319
+192,604
| +4% | +$2.59M | ﹤0.01% | 1818 |
|
|
2018
Q3 | $106M | Buy |
5,461,715
+209,939
| +4% | +$4.07M | ﹤0.01% | 1772 |
|
|
2018
Q2 | $134M | Buy |
5,251,776
+536,901
| +11% | +$13.7M | 0.01% | 1624 |
|
|
2018
Q1 | $95M | Buy |
4,714,875
+243,217
| +5% | +$4.9M | ﹤0.01% | 1739 |
|
|
2017
Q4 | $89.7M | Buy |
4,471,658
+178,191
| +4% | +$3.58M | ﹤0.01% | 1779 |
|
|
2017
Q3 | $88.9M | Buy |
4,293,467
+216,322
| +5% | +$4.48M | ﹤0.01% | 1774 |
|
|
2017
Q2 | $60.3M | Buy |
4,077,145
+210,334
| +5% | +$3.11M | ﹤0.01% | 1927 |
|
|
2017
Q1 | $61.7M | Buy |
3,866,811
+481,710
| +14% | +$7.68M | ﹤0.01% | 1904 |
|
|
2016
Q4 | $42.7M | Sell |
3,385,101
-131,823
| -4% | -$1.66M | ﹤0.01% | 2056 |
|
|
2016
Q3 | $98.5M | Buy |
3,516,924
+182,914
| +5% | +$5.12M | 0.01% | 1567 |
|
|
2016
Q2 | $117M | Buy |
3,334,010
+289,571
| +10% | +$10.1M | 0.01% | 1415 |
|
|
2016
Q1 | $83.4M | Buy |
3,044,439
+349,353
| +13% | +$9.57M | 0.01% | 1596 |
|
|
2015
Q4 | $92.2M | Buy |
2,695,086
+316,722
| +13% | +$10.8M | 0.01% | 1526 |
|
|
2015
Q3 | $68.3M | Buy |
2,378,364
+359,993
| +18% | +$10.3M | ﹤0.01% | 1700 |
|
|
2015
Q2 | $90.3M | Buy |
2,018,371
+740,931
| +58% | +$33.2M | 0.01% | 1591 |
|
|
2015
Q1 | $44.2M | Buy |
1,277,440
+610,840
| +92% | +$21.1M | ﹤0.01% | 1973 |
|
|
2014
Q4 | $18.2M | Buy |
+666,600
| New | +$18.2M | ﹤0.01% | 2269 |
|